We enable biological engineering at a genome-scale

We provide our partners with groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products, and conduct otherwise unapproachable scientific research.

Neochromosome is uniquely suited to accelerate this work. Our first-in-class capabilities were developed to design, build, and test the world’s first fully synthetic eukaryotic cells. Today, we offer our services and platform — from highly automated synthesis of complex DNA to de novo design, synthesis, and delivery of chromosomes – to researchers and organizations around the world.

Neo is a subsidiary of Opentrons Labworks. Neo leverages Opentrons’ robotics and automation for its world class genome foundry.